Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 study of Zika vaccine in patients with zika infection

Trial Profile

Phase 1 study of Zika vaccine in patients with zika infection

Planning
Phase of Trial: Phase I

Latest Information Update: 05 May 2016

At a glance

  • Drugs Zika virus vaccine-Pharos (Primary)
  • Indications Zika virus infection
  • Focus Adverse reactions
  • Most Recent Events

    • 05 May 2016 New trial record
    • 02 May 2016 According to Pharos Biologicals media release, company will initiate this study by autumn of 2016.

Trial Overview

Purpose

This study will investigate the effect of Zika vaccine in patients with zika infection.

Diseases Treated

Indication Qualifiers Patient Segments
Zika virus infection treatment -

Subjects

  • Subject Type patients
  • Sex male & female
  • Age Group adult

Patient Inclusion Criteria

- patients with zika infection

Trial Details

Organisations

  • Affiliations Pharos Biologicals

Trial Dates

Other Details

  • Design prospective
  • Phase of Trial Phase I
  • Location Unknown
  • Focus Adverse reactions

Interventions

Drugs Route Formulation
Zika virus vaccine-PharosPrimary Drug
-
-

Zika-virus-vaccine

Trial History

Event Date Event Type Comment
05 May 2016 New trial record New trial record Updated 05 May 2016
02 May 2016 Other trial event According to Pharos Biologicals media release, company will initiate this study by autumn of 2016. Updated 05 May 2016

References

  1. Pharos Biologicals. Pharos Biologicals Conducting Tests of a Novel Zika Vaccine. Media-Rel 2016;.

    Media Release
Back to top